Loading clinical trials...
Loading clinical trials...
A Multi-Center, Randomized, Double-Masked Evaluation of the Efficacy of Cetirizine 0.1%/Fluticasone 0.005% Ophthalmic Solution Compared to Its Components and Vehicle in a Modified Conjunctival Allergen Challenge (CAC) Model During Pollen Season
The purpose of this study is to evaluate the efficacy of AC-150 compared to vehicle and its components in the prevention of the signs and symptoms of allergic conjunctivitis in Enviro-CAC™ Model.
Age
10 - No limit years
Sex
ALL
Healthy Volunteers
No
Ora, Inc
Andover, Massachusetts, United States
Start Date
May 1, 2010
Primary Completion Date
July 1, 2010
Completion Date
July 1, 2010
Last Updated
September 14, 2017
83
ACTUAL participants
AC-150 Combo
DRUG
AC-150A 0.1%
DRUG
AC-150B 0.005%
DRUG
Vehicle
DRUG
Lead Sponsor
Aciex Therapeutics, Inc.
NCT05839938
NCT05186025
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and ConditionsNCT05191186